A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a dose escalation trial. The dosing regimen involves a single-dose study. This is a single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetic characteristics of TQC3927 powder for inhalation in healthy adults subjects.
Epistemonikos ID: c6710706ae1248b423f30298ee751b21a4ea960c
First added on: May 22, 2024